Yifan Zhai

Executive

US·SEC (Form 4)

Ascentage Pharma Group International

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 22 May 2026 for ASCENTAGE PHARMA GROUP INTERNATIONAL. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Yifan Zhai: trading record in brief

Yifan Zhai discloses dealings in Ascentage Pharma Group International to SEC (Form 4). Activity is concentrated on a single trading day, 21 May 2026, with 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 22 May 2026, reports an option exercise in Ascentage Pharma Group International. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.